Semble Secures $30 Million in Latest Series C Funding Round

Semble secured $30 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

Semble Raises $30 million in Funding

Semble is a M in Series C Funding. Semble, a London-based Digital Health company focused on accelerate the rollout of its care orchestration platform across the UK and Europe.

Investors Behind the Funding

The round was backed by Revaia. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Semble operates in Healthcare & Life Sciences. Semble's Series C round shows investors are still backing digital health platforms with real scale narratives. At $30M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

accelerate the rollout of its care orchestration platform across the UK and Europe

Looking Ahead

Semble Raises £30M in Series C Funding

Source reference: original announcement/article.